undamentalytics Newsletter
Sign in

Envista Holdings Corp revenue

Envista Holdings Corp's revenue was $2.72bn in fiscal 2025, up 8.3% on the year before. Since fiscal 2017 ($2.81bn) it has grown at a compound -0.4% a year. Over the last twelve months it was $2.86bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJul 2026
Revenue2,8112,8452,2851,9292,5092,5692,5672,5112,7202,857
Growth on the year before—+1.2%−19.7%−15.6%+30.1%+2.4%−0.1%−2.2%+8.3%—
Gross profit1,6211,6021,3491,0551,4271,4751,4411,3731,4871,578
Gross margin57.7%56.3%59.1%54.7%56.9%57.4%56.1%54.7%54.7%55.2%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Specialty Products and Technologies $1.8B 64.5% ▲ 8.4%
Equipment and Consumables $967M 35.5% ▲ 8.1%
Geography
Region Revenue YoY
North America $1.4B ▲ 6.9%
United States $1.3B ▲ 6.5%
All Other Countries $1.2B ▲ 11.6%
Western Europe $615M ▲ 12.7%
High Growth Markets $586M ▲ 8.8%
China $194M ▲ 0.5%
Other Developed Markets $123M ▲ 2.1%

These categories overlap or exclude eliminations, so shares aren't shown.

From Envista Holdings Corp's 10-K filed February 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Supplies: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Envista Holdings Corp $2.86bn 11.9% 3.4%
West Pharmaceutical Services $3.40bn 12.6% 5.1%
Dentsply Sirona Inc. $3.64bn -0.8% -2.5%
ICU Medical Inc $2.16bn -9.0% -2.0%
Align Technology $4.14bn 4.4% 3.5%
The Cooper Companies $4.24bn 4.7% 6.4%

Compare with peers

Head to head: NVST vs WSTNVST vs XRAYICUI vs NVST

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Envista Holdings Corp's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envista Holdings Corp.